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Cervical cancer is the fourth most common cancer and fourth most common cause of 
cancer-related death in women in the world. Current guidelines for cervical cancer screening 
recommend a Pap and/or human papillomavirus test and a follow-up colposcopy if particular 
abnormalities are discovered. In many patients, colposcopies cause significant levels of anxiety, 
adversely impacting patients’ pain tolerance and adherence to follow-up. Previous studies have 
shown mixed results on whether video colposcopy decreases this anxiety. Moreover, these 
effects have not been assessed in low-income communities who are disproportionally affected by 
cervical cancer. In this study, we will conduct a single blind randomized controlled trial to 
determine whether video colposcopy decreases anxiety associated with colposcopy in low-
income patients. This study may help demonstrate the effectiveness of video educational 
interventions in reducing anxiety, potentially establishing video colposcopy as a useful addition 
to standard colposcopy practice in this patient population. 
 
1 
Chapter 1: Introduction 
1.1 BACKGROUND 
Cervical cancer is a slowly developing cancer that is most commonly caused by 
persistent infections with the human papillomavirus (HPV) and is largely preventable with 
the HPV vaccine. Currently, it is both the fourth most common cancer and the fourth most 
common cause of cancer-related death in women across the globe with a current estimated 
incidence rate of 13.1 per 100,000 and a prevalence of about 1,939,000.1-4 In 2015, this cost 
the United States an estimated $3.3 billion due to direct healthcare costs and lost productivity 
costs from missed work or early death.5  
Since the 1950’s, the incidence of cervical cancer and its associated mortality has 
significantly decreased in the United States. For 2020, the American Cancer Society 
estimates that there will be 13, 800 new cases and an estimated 4,290 deaths due to cervical 
cancer.6 This decrease in disease burden is largely due to the success of early detection and 
screening programs with HPV testing and the Pap test which can identify precancerous 
lesions called cervical intra-epithelial neoplasia (CIN) before it progresses to invasive 
cervical cancer.7 Abnormal findings are often followed up with colposcopy where the cervix 
is visualized. During the procedure, cervical biopsies, endocervical curettage, or treatment 
may also occur if warranted. In the last few decades, this downward trend has stagnated 
indicating the need for improvements in rates of screening, in the screening test itself, and in 
subsequent evaluation and management of abnormal screening results.6 One aspect requiring 
improvement is the significant level of anxiety women experience during all stages of the 
cervical cancer screening process, and especially during colposcopy. 8-11 As this anxiety often 




suboptimal adherence to critical follow-up care, further research and development into 
effective interventions to decrease anxiety is warranted to improve these health outcomes.12-
15 
In previous studies, it has been shown that the anxiety associated with colposcopy is 
due to several factors. Some of the factors include inadequate understanding of cervical 
cancer screening, fear of pain or discomfort during the procedure, worries about sexual 
dysfunction, and fear of potentially having cancer.9-11,13,16 One study found that some women 
thought that coming in for a Pap smear meant that their medical provider thought they had 
cancer.17 Other studies have found that women thought that cervical cancer was either 
incurable or unpreventable.17,18 With these beliefs about cervical cancer screening in mind, it 
is not surprising that in 2003 the National Assessment of Adult Literacy found that only an 
estimated 12% of Americans had proficient health literacy with the majority of Americans 
having intermediate health literacy with basic health information and services.19 This is 
especially concerning as past research has demonstrated that patients with poor health 
literacy experience higher anxiety and distress levels.20,21 Thus, the data strongly suggests 
that providing more information about colposcopy and the cervical cancer screening process, 
and using tools that increase patient engagement could potentially reduce anxiety levels in 
these patients. 
As such, several studies in the past have attempted to decrease this anxiety using 
educational and information sharing interventions. These interventions include information 
leaflets, informational videos, pre-colposcopy counselling, and individually targeted 
information.8,22-28 Of the studies that looked at the utility of providing informational leaflets 




information reduced anxiety while other larger studies found that their informational leaflet 
did not provide any anxiety relief.24,25,28 Inconsistent results have been similarly reported in 
studies looking at informational videos prior to colposcopy: one study showed a significant 
decrease in patient anxiety while two others showed no significant decrease in patient anxiety 
levels.8,22,29 Providing pre-colposcopy counselling or individually targeted information over 
the phone and in the mail found negligible effects on reducing anxiety levels as well.23,26,27,30 
Ultimately, a  2011 Cochrane review of six randomized controlled trials conducted by Galaal 
et al., concluded that of these interventions, only watching an informational video in addition 
to an information leaflet showed any significant effect on decreasing anxiety levels in women 
undergoing colposcopies.31  
Alternative strategies for decreasing patient anxiety include the use of music and 
mind-body interventions. It is hypothesized that these tools may be effective not as a way to 
provide additional knowledge, but either as a means to distract or calm those undergoing 
colposcopy. One study conducted in Chinese patients found that the use of slow rhythm 
music significantly decreased patients’ anxiety levels as measured through the Spielberger 
State Trait Anxiety Inventory (STAI).32 Similar results are reported in another study 
conducted among adolescents that found that music videos decreased patient’s body 
movements indicative of pain or distress during the colposcopic examination.33 However, 
recently there have been several studies reporting the opposite result.34-37 A systematic 
review and meta-analysis of five randomized controlled trials on the effect of music therapy 
by Abdelhakim et al. concluded that music had no significant effect on decreasing anxiety 
levels in patients presenting for colposcopy.38 However, it should be noted that none of these 




heterogeneity of results.32,34-37 Mind body interventions like guided imagery have also found 
no effect on reducing patient’s anxiety levels.34 Thus, current available evidence for the use 
of distraction or calming tools during colposcopy indicates that they are at best, minimally 
effective in reducing patient anxiety levels. 
 The use of video colposcopy as a tool to decrease patient anxiety shows some 
potential. Thus far, only a few experimental studies have investigated its effectiveness with 
variable results. One study conducted by Walsh et al. found that the use of video colposcopy 
in consecutive colposcopies significantly decreased self-reported anxiety levels during the 
colposcopic examination in a group of patients in Ireland.14 Another study found the same 
result but only in a subset of patients who scan for threats and seek out information in 
response to psychological stress.39 Two other studies have found results inconsistent with 
these findings. The study conducted by Rickert et al., who studied adolescents, found that 
video colposcopy did not result in significant STAI score differences between the video 
colposcopy group and the control group.33 Similarly and more recently, in a large 
randomized controlled trial, Hilal et al. found that video colposcopy had no significant effect 
on reducing anxiety levels in German women presenting for first time colposcopy measured 
using the STAI before and after the colposcopic exam.40 This heterogeneity of results might 
be explained by the different patient populations studied in these trials as well as 
methodological differences in the study designs. Demographic characteristics in several of 
these studies did not include race, ethnicity, or socioeconomic status and so comprehensive 
comparisons between the studies are unable to be reliably drawn and extrapolated into other 




protocol differences, further investigation is needed to determine if similar effects will be 
seen with the use of video colposcopy across different patient populations. 
As the majority of these studies were conducted in Europe, whose patient populations 
are considerably different from the U.S., the utility of video colposcopy as a strategy to 
decrease anxiety in low-income patients is still unknown. Evidence in the literature suggests 
that culture has significant influences on how individuals experience anxiety, suggesting that 
patient populations from different cultures may react to video colposcopy differently as an 
intervention to reduce anxiety.41,42 Moreover, none of these studies have looked at low-
income populations in the U.S. who are predominantly racial and ethnic minorities who have 
the highest burden of cervical precancer and cancer in America.43-45 This highlights the need 
for more research into these vulnerable groups. According to the article by Singh et al, from 
2009-2013, women in the lowest socioeconomic status (SES) bracket had a 76% higher 
cervical cancer mortality rate than women from the highest SES bracket.43 Health disparities 
by race and ethnicity also continue to persist in cervical cancer statistics in the U.S. As of 
2016, incidence rates and mortality rates from cervical cancer have been found to be higher 
in black women and Hispanic women compared to white women at 8.7 and 9.8 versus 7.5 per 
100,000 and 3.1 and 2.7 versus 2.1 per 100,000, respectively.45,46 Poor health literacy also 
afflict these low-income and minority populations illustrating the urgent need to identify 
interventions to target their lack of knowledge and in doing so, decrease their anxiety upon 
presentation for colposcopy.47-49 Fortunately, previous research has demonstrated that the use 
of culturally sensitive and targeted video technology can help increase patient knowledge and 




into video colposcopy is warranted to evaluate whether it is a useful intervention to decrease 
anxiety in these low-income patients undergoing first time colposcopy. 
1.2 STATEMENT OF THE PROBLEM 
A few randomized controlled trials to date have examined video colposcopy as a 
potential tool to decrease anxiety in patients presenting for first-time colposcopy. Previous 
studies have produced mixed results on its efficacy with some studies demonstrating a 
benefit with video colposcopy and others demonstrating none. However, these current studies 
are limited in the interpretation of their results as several of them feature design elements that 
introduce sources of bias and are limited in generalizability. These design elements range 
from using a poor method to randomize patients to failing to account for certain confounders. 
Moreover, each of the four published randomized controlled trials studied a different 
population of interest and failed to report important sociodemographic information on their 
sample populations.14,33,39,40 Given the limited external validity of these studies, the utility of 
video colposcopy to decrease anxiety remains unknown in low-income and minority patients 
who are disproportionately affected by cervical cancer in the United States. The proposed 
study will be a randomized controlled trial to determine the efficacy of video colposcopy in 
reducing anxiety in a population who is grossly understudied and has the potential to benefit 
greatly from the results. 
1.3 GOAL AND OBJECTIVES 
The goal of this proposal is to determine whether video colposcopy is a useful tool to 
effectively decrease anxiety levels in low-income women undergoing colposcopy for the first 
time. The proposed study will evaluate whether the use of video colposcopy as an interactive 




anxiety levels compared to standard non-video colposcopy and improve adherence to follow-
up in these patients. The primary outcome will be the mean reduction in anxiety. Patient 
adherence to follow-up, patient satisfaction, patient knowledge of colposcopy and cervical 
dysplasia, and patient pain during the colposcopic exam will also be measured to determine if 
video colposcopy improves these secondary outcomes. This study ultimately hopes to inform 
colposcopy practice on a way to decrease anxiety in first time colposcopy patients. 
1.4 HYPOTHESIS 
We hypothesize that low-income patients presenting for first time colposcopy 
randomized to video colposcopy will have a different mean change from baseline in the 
Spielberger State Trait Anxiety Inventory (STAI) when compared to those patients 
undergoing traditional non-video colposcopy. 
1.5 DEFINITIONS 
Video Colposcopy: Video colposcopy utilizes a video colposcope to enable both the 
clinician and the patient to view in real time, the cervical examination that is being performed 
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Chapter 2: Review of Literature 
2.1 INTRODUCTION 
 We conducted a comprehensive search from the following databases between June 
2019 and May 2020: PubMed, Ovid MEDLINE, EMBASE, and PsycINFO, Cochrane 
Library, Scopus, and Sociological Abstracts. The following terms or a combination of these 
terms were used to search for relevant literature: colposcopy, video colposcopy, colposcope, 
anxiety, State Trait Anxiety Inventory, fear, pain, cervical cancer, cervical cancer guidelines, 
anxiety across cultures, adherence, patient satisfaction, patient knowledge and health 
literacy. Key terms used to search for protocol and methodology specific determinations 
included: confounders, side effects, and safety. Articles in the English language or English 
translations were evaluated for theoretical soundness, strength of design, and significance of 
data. Pertinent articles were included and further analyzed in this review. 
2.2 CERVICAL CANCER,  SCREENING, AND ANXIETY 
 Cervical cancer occurs when cells in the cervix undergo abnormal changes most 
commonly caused by oncogenic strains of the human papillomavirus (HPV). This process 
usually occurs over several years and therefore most women who are diagnosed with cervical 
cancer are usually between the ages of 44 and 68.1 Because this cancer develops over a 
relatively long period of time, it is one of the very few cancers that is largely preventable 
with the HPV vaccine and cervical cancer screening programs.  
 The cervical cancer screening process begins at age 21 for women in the U.S. The 
U.S. Preventative Task Force currently recommends that women aged 21-29 receive a Pap 
test every 3 years and women aged 30-65 screen with a Pap test alone every 3 years, high-




certain abnormalities are found, women are subsequently referred for a colposcopy, a 
standard diagnostic procedure that uses a stereoscopic binocular microscope to visualize the 
cervix and obtain biopsies of any areas suspicious for neoplasia. In the literature, it has been 
well documented that women experience significant levels of anxiety both before and during 
this procedure.3-7 As this anxiety with colposcopy has been associated with decreased pain 
tolerance, psychosocial and psychosexual dysfunction, and decreased adherence to follow up, 
various interventions have been developed to help provide anxiety relief in these patients.7-12 
2.3 REVIEW OF PREVIOUS INTERVENTIONS TO REDUCE ANXIETY 
 Several strategies have been investigated to help decrease anxiety in women attending 
their first colposcopy with educational and distraction or calming interventions being the 
most studied. The following detailed review consists of several trials that have tested the 
utility and efficacy of these interventions. 
Informational Leaflets and Booklets 
One strategy used to decrease anxiety has been to provide informational leaflets or 
booklets to patients prior to colposcopy. Three studies to date have investigated their use 
with varied results. One small study (n=64) conducted by Marteau et al., showed that sending 
a simple informational booklet in the mail prior to colposcopy that contained procedural 
information, behavioral instructions, and outcome information significantly decreased 
patients’ anxiety.13 In the study, there were 4 different groups. Group 1 underwent routine 
care, Group 2 was sent a simple informational booklet, Group 3 was sent a complex 
informational booklet, and Group 4 was sent both booklets. Anxiety was measured using the 
state scale of the Spielberger State Trait Anxiety Inventory (STAI), a validated scale of 




20-80 with higher scores indicating higher anxiety. Scores were compared at two time points: 
upon receipt of the colposcopy appointment and right before colposcopy. The first STAI 
scores were taken after receipt of any booklets in the mail. 
The STAI scores of the groups were as follows upon receipt of appointment: Group 
1=46.2, Group 2= 43.9, Group 3= 46.8, and Group 4=38.3, p <.05. The following STAI 
scores were those obtained at the appointment: Group 1= 50.7, Group 2= 44.8, Group 
3=49.1, and Group 4=42.1, p <.025. At both time points, Group 2 and Group 4 had 
significantly different mean STAI scores compared to Groups 1 and 3. The authors thus 
concluded that those groups that received the simple informational booklet were less anxious 
after receipt of the simple booklet compared to those groups who did not receive it.  
However,  while this study demonstrates some significant anxiety reduction with an 
informational booklet, there are some limitations to this study. One limitation is the absence 
of confirmation that the women who were sent the informational booklets in the mail actually 
read them. Thus, caution must be taken to attribute the differences in anxiety to the simple 
informational booklet alone as it is possible the women also relied on other sources of 
information. Another limitation is the small number of participants in each group (Group 1: 
n=13, Group 2: n=21, Group 3: n=15, and Group 4: n=15) as well as the absence of sample 
size calculations. These aspects of the study call into question whether this study was 
powered correctly to detect a clinically significant effect size.  
Two larger randomized controlled trials evaluated the provision of informational 
leaflets or handouts prior to colposcopy and found results contrary to those found by Marteau 
et al.15,16 Tomaino-Brunner et al. (n=113) conducted a quasi- randomized controlled trial 




scheduled for a colposcopy. This study found no significant difference in STAI scores 
between those who received an educational handout in the mail one week prior to the 
colposcopy and those who did not.15 STAI scores prior to the colposcopy in the intervention 
group and the control group were 47.9 12.8 and 50.813.3, respectively. The difference in 
STAI scores was not found to be significant (p-values were reported as nonsignificant but no 
specific values were reported). However, it should be noted that the authors powered their 
study based only on knowledge of colposcopy and not on STAI scores. Based on a previous 
study the investigators had conducted, they found that only 30% of women knew what a 
colposcopy was and used this percentage as their estimated effect size in their sample size 
calculations.15 One methodological weakness of this study includes the method of allocation 
which used a randomization scheme based on the week of scheduled appointment rather than 
a truly random allocation, increasing the risk of selection bias. The lack of a pre- and post- 
test design also makes it hard to determine if the handout was truly the variable that produced 
the end results. The results of Howells et al. support those found by Tomaino-Brunner et al. 
In a prospective randomized controlled trial (n=200), they found that the provision of 
informational leaflets prior to colposcopy did not produce a statistically significant difference 
in STAI scores between the intervention and control groups, either before colposcopy or at 
the 6-month follow-up visit.16  
It should also be noted that the studies conducted by Marteau et al. and Howells et al. 
are limited in terms of their external validity as neither study listed demographic information 
concerning race and ethnicity or SES. Thus, the generalizability of their results to other 




inconsistent and inconclusive regarding the efficacy of these interventions in reducing 
anxiety. 
Pre-colposcopy Informational or Counseling Sessions 
Pre-colposcopy information sessions with counselling have been evaluated in three 
randomized controlled trials but have shown negative results. In a quasi- randomized 
controlled trial conducted by Sarkar et al. (n=59), women who received an even hospital 
number received counseling by the clinic nurses before filling out a questionnaire about 
anxiety and depression.17 Women who received an odd number filled out the questionnaire 
before they received counselling. Anxiety was measured using the STAI and no significant 
differences between the mean STAI scores were seen between groups. In two other studies 
(n= 147-220), informational leaflets and video information were provided to both the 
intervention group and the control group prior to colposcopy. 18,19 In addition to these 
resources, an additional discussion with an experienced colposcopy nurse was provided in 
the study by Chan et al. and pre-colposcopy group sessions with a colposcopy nurse was 
provided in the study by Byrom et al. to the intervention group. No significant differences in 
mean STAI scores between groups were detected in either of the studies.18,19 The mean STAI 
score in the study by Chan et al. prior to the colposcopic examination was 45.2111.88 in the 
intervention group and 45.819.89 in the control group.18 In the Byrom et al. study, the mean 
pre-colposcopy STAI score was 46.36 11.98 in the intervention group and 45.94  13.99 in 
the control group. However, the study conducted by Byrom et al. did not recruit enough 
participants to achieve their sample size to power the study. Thus, the study may not have 
been large enough to detect the effect size. Similar to previously mentioned studies, all three 




only recruited Chinese patients and the studies conducted by Sarkar and Byrom et al. did not 
report race and ethnicity or SES data. 
Targeted Information 
As anxiety can be quite individualized, one randomized controlled trial published in 
2011 by De Bie et al., looked at whether targeted information through the mail or telephone 
would provide any anxiety relief to these women. 20 Women who were randomized to the 
intervention group received a phone call that included topics about the Pap result, precancer 
versus cancer, the colposcopic procedure, treatment, HPV, HPV vaccination, and fertility. 
They also received a document that included information about the screening program, 
abnormal smear results, and steps after an abnormal smear result. The control group received 
a 2-page informational leaflet that included information about colposcopy and treatment. 
Anxiety was measure using the STAI on arrival to the colposcopy clinic. The median STAI 
score for the intervention group was 48.0 (42.0-56.0) and the median STAI score for the 
control group was 50.0 (40.0-59.0), p=0.92. Thus, no significant difference was found 
between the median scores between the intervention group and the control group with 
targeted information over the phone and in the mail.  
Informational Video 
Studies conducted by Freeman et al., Ketalaars et al., and Wouters et al., have 
assessed the utility of an informational video as a medium to decrease anxiety. The earliest of 
these studies (n=93) by Freeman et al. in 2001, utilized a 7-minute clinic-specific video that 
included information about abnormal Pap smears, the consultation, and possible treatments.4 
This videotape and a standard explanatory leaflet were sent to women in the intervention 




was sent to the women in the control group. Anxiety was measured using the STAI at the 
woman’s first attendance to the clinic. The mean STAI score of those who received the video 
and the leaflet was 43.2 12.09 while the mean STAI score of those who only received the 
leaflet was 54.7  12.58, P=.00004. The authors therefore concluded that the video 
significantly reduced their patients’ anxiety. The videotape cost £1.50 for each woman in the 
video group making it more likely that these women did indeed watch the video compared to 
if the videotape was free. This is because there is a monetary loss if the women choose not to 
watch the video. However, there was no formal verification that the women who received the 
videotape actually watched the video. Thus, these results must be interpreted in the context of 
this limitation. 
 Two recent larger randomized controlled trials provide contradictory results to those 
found by this study. In 2017, Ketalaars et al. (n=136) examined the efficacy of an 11-minute 
video prior to colposcopy in decreasing anxiety. The content of the video was very similar to 
the one used by Freeman et al., and included hospital and clinic specific images as well as 
explanations of abnormal smears, the consultation, and possible treatments.21 Women 
randomized to the intervention group received a link and password through the internet for 
the online video and the standard informational brochure through the mail and women 
randomized to the control group only received the standard informational brochure. The 
primary outcome was difference in anxiety between the groups as measured by the STAI and 
the Hospital Anxiety and Depression Scale (HADS). The mean STAI score after the 
invention in the video group was 44.3 10.7 while the mean STAI score in the control group 
was 44.9 11.0, p= .752. The mean HADS anxiety score after the intervention in the video 




Neither of these measures was found to be statistically different between the two groups and 
the authors concluded that video information did not reduce anxiety levels in women referred 
for their first-time colposcopy.  
The results of the previous study are supported by Wouters et al. In 2019, Wouters et 
al. (n=122) studied the effect of a hospital-independent animation video on consultation time, 
anxiety and satisfaction.22 The methods of this study were similar to the prior studies. The 
animation video included information on different cytology results, the colposcopy 
procedure, possible treatments, possible side effects, and follow-up procedures. Women in 
the intervention group received this video and standard written and oral information on 
colposcopy and the control group just received the written and oral information prior to 
colposcopy. Anxiety was measured via the STAI and the HADS. The pre-colposcopy mean 
STAI score in the animation video group was 46.8 10.4 and was 44.210.6 in the control 
group, p=0.16. The pre-colposcopy mean HADS anxiety score in the animation video group 
was 4.0 (2.5-6.0) and 4.0 (2.8-5.3) in the control group, p=0.58. Thus, no significant 
difference in mean STAI or HADS was observed between the two groups. 
In reviewing these three studies, it should be noted that all three studies are either 
limited or uncertain in terms of their external validity. Freeman et al. conducted their study in 
London, England, and only state that there are no differences between the two groups but 
failed to display any demographic information. Thus, it is unknown whether the results they 
see in their study can be applied to other populations of women. The same problem limits the 
generalizability of the studies done in the Netherlands by Ketalaars et al. and Wouters et al. 
as they both fail to report the race and ethnicity or SES of their participants. It could be 




the information that is currently available, no definitive conclusions on video interventions 
can be made on reducing anxiety in the population of women we will be studying, as the 
populations studied thus far are not representative of those in the U.S. 
Music 
In addition to educational interventions, a few other distraction or calming tools have 
been evaluated to provide anxiety relief. Several studies have looked at music.  
One of the first studies looking at music was conducted in 1994 by Rickert et al. who 
conducted two consecutively occurring studies that examined the effect of music videos and 
video colposcopy on decreasing anxiety in adolescents presenting for colposcopy.23 The 
results of the video colposcopy study will be discussed later in the section titled “Overview 
of Video Colposcopy.” In the study assessing music videos, 30 patients aged 13-20 were 
randomized to either the music video group or to the control group. The music video was 
selected prior to the exam and each participant watched the same music video. Several 
measures were used to assess anxiety including behaviors indicative of distress, the STAI, 
and heart rate. Some of the behaviors indicative of distress included the clinician giving 
reassuring comments to the patient or the patient commenting on pain. These behaviors were 
then coded into a list and an observer recorded the frequencies of these behaviors throughout 
the exam. They found that those participants in the music video group demonstrated 
significantly fewer behaviors and body movements indicative of pain and discomfort 
(P<.003), less reassurance from the provider (P<.05) and required fewer explanations from 
the clinician (P<0.007). Other behaviors, STAI and heart rate were found to be non-
significant. Thus, the authors concluded that the music video had a positive effect on anxiety 




longer recommended for routine cervical cancer screening, the generalizability of these 
results is fairly limited. Additionally, the measure that was found to be significant in this 
study (coded behaviors indicative of distress) is not well-validated, making the results less 
reliable. 
A study conducted by Chan et al. in 2003 examined the effects of instrumental music 
to decrease anxiety in a group of 220 Chinese women and provide further support for the 
results found by Rickert et al.24 Patients filled out the STAI questionnaire (translated into 
Chinese) prior to colposcopy and again after the procedure. Slow rhythm instrumental music 
was played on speakers to those women randomized to the music group. The colposcopic 
exam was performed by a gynecological oncologist or a gynecologist with an interest in 
colposcopy, but no standard format of counseling was used among these clinicians. Using 
mean STAI score as one of their primary outcomes, music was found to significantly reduce 
anxiety in women presenting for first time colposcopy. Women in the music group had a 
mean post-colposcopy STAI of 39.36 (95% CI 37.33-41.39) compared to women in the 
control group whose mean post-colposcopy STAI was 44.16 (95% CI 41.82-46.49).24 A 
Cochrane review by Galaal et al. examining six studies on interventions for reducing anxiety 
in women undergoing colposcopy found that this reasonable large study had a low risk of 
bias based on its random sequence generation and concealment of allocation.25 It should be 
noted however that this study was only conducted among Chinese women, utilized multiple 
clinicians to perform the colposcopy, and did not examine whether the music affected 
physician behavior and performance, in effect limiting the generalizability of the study and 




In contrast to the results of those found by Rickert et al. and Chan et al., many studies 
have found that music does not significantly decrease anxiety in women presenting for 
colposcopy. One study conducted by Danhauer et al. in 2007 examined the effect of music 
and guided imagery on decreasing anxiety in a reduced-fee colposcopy clinic.26 The aim of 
their study was to determine if mind-body interventions could decrease anxiety and perceived 
pain. 170 women were randomized to three groups: a music group, a guided imagery group, 
or a usual care group. The women that were randomized to the music intervention were 
provided several different music options on a compact disc (CD) including classical, harp, 
general instrumental, or nature sounds through headphones. Women in the guided imagery 
intervention were provided a CD with an audio recording titled A Meditation to Help you Be 
Relaxed and Awake During Medical Procedures by Naparstek. Using mean STAI as their 
primary outcome, they found no significant difference in either the music intervention group 
or the guided imagery group compared to the usual care group.26 Interpretation of these 
results should take note that 31.9% of the women recruited reported that they have had a 
prior colposcopy before, possibly confounding the results. Like the study conducted by Chan 
et al., this study also had multiple clinicians performing the colposcopy which again may bias 
the results. 
A single-blind prospective randomized controlled superiority trial by Mak et al. in 
2017 also examined the effect of music in gynecological procedures on pain, anxiety, and 
patient satisfaction. Patients were stratified by hysteroscopy and colposcopy. Those in the 
music intervention group were provided several different music options including pop, 
classical, and spa music which was played on an iPod with speakers during the procedure.27 




Scale (VAS) from 0-100 mm and one of their secondary outcomes was anxiety measured 
using the STAI before and after the procedure. They found that there was no significant 
difference in pain or anxiety between the music group and the control group. 27 One 
particular and unique strength of this study was that it was single blinded. Participants in the 
study were only told that they would be participating in a study about pain relief and not the 
role of music, reducing response bias. However, while this study showed no significant 
difference with music in lowering anxiety, a number of limitations must be highlighted. This 
includes the various options of music provided to the patients, the various providers who 
performed the colposcopy, and the lack of documentation of waiting time and duration of the 
procedure which all may act as confounders in this study, limiting the interpretations of these 
results. 
Two other additional studies mirror the results found by Danhauer et al. and Mak et 
al. These studies conducted by Chantawong et al. in 2017 and Hilal et al. in 2018 used only 
one type of music to assess whether music could decrease anxiety.28,29 Chantawong et al. 
played relaxing modern western style instrumental music in a stereo headset during loop 
electrosurgical excision procedures in 150 patients while Hilal et al. played Mozart’s 
symphony No. 40 during colposcopy in 205 patients. The primary outcome examined in the 
study by Chantawong et al. was procedural pain and baseline pain scores with anxiety as a 
secondary outcome measured through the VAS. The primary outcome of the study conducted 
by Hilal et al. was reduction in mean STAI. Like previous studies, both studies did not find 
significant differences between the music and control groups.28,29 
Additionally, a recent systematic review and meta-analysis by Abdelhakim et al. of 




seen with music therapy in reducing anxiety levels compared with the control group.30 When 
analyzing the data, they found that there was a high heterogeneity of results. However, once 
the study conducted by Chan et al., was removed, this completely resolved. Thus, it seems 
that the results from the Chan et al. study, as mentioned previously, may be limited to the 
primarily Chinese population that was studied. 
2.4 OVERVIEW OF VIDEO COLPOSCOPY 
Previous Studies Assessing Video Colposcopy to Decrease Anxiety 
 To date, the specific use of video colposcopy as a tool to decrease anxiety has been 
studied in a few populations of interest. The first reported study in the literature assessing 
video colposcopy to decrease anxiety was in adolescents in 1994 in the same article 
mentioned previously assessing the use of music videos to decrease anxiety in adolescents.23 
This small study (n=27) recruited female adolescents aged 13-20 years and randomized them 
to either the video colposcopy group or the control group.23 Multiple measures of anxiety 
were measured including a list of behaviors indicative of distress, STAI, and heart rate. The 
list of behaviors indicative of distress included items like reassurance from the clinician or 
comments about pain. 23 These behaviors were coded and the frequency of these behaviors 
was then documented during the procedure. Study participants randomized to the video 
colposcopy group were told they could watch the procedure on the television monitor but 
were not forced to do so. The only significant difference demonstrated amongst participants 
randomized to video colposcopy versus traditional colposcopy was that subjects in the 
control group provided more responses to the provider inquiring about their pain or 
discomfort.23 All other measures were nonsignificant. However, several elements of the study 




each patient was randomized to each group. As the study only reported that patients were 
randomized but not how, it is unclear if selection bias was actually eliminated. Similarly, 
there is no mention of whether there was any concealment of allocation, introducing another 
source of potential bias. The sample size of the study is also small (n=27), reducing the 
statistical power of the study. Furthermore, there is no mention of sample size calculations 
making it difficult to assess whether the study recruited enough participants to detect a 
difference in effect between the two groups.  In terms of measured outcomes, the use of the 
list of coded behaviors is unvalidated, making these results somewhat unreliable. Finally, 
while the study reports that there were no significant baseline differences in their patients or 
in the other measures of anxiety like STAI and heart rate, they failed to display this data in 
their paper and did not speak about possible confounders and whether they were adjusted for 
in their analysis. Thus, while this study produced a negative result, the reported results must 
be interpreted in the context of these various limitations. 
 In 2004, one relatively small quasi-randomized controlled study (n=81), conducted in 
Ireland demonstrated that the use of video colposcopy in consecutive colposcopies 
significantly reduced anxiety in patients compared to traditional colposcopy.10 Patients 
presenting for first time colposcopy were randomly assigned to the video colposcopy or 
control group in strict alternating rotation and the same clinician and nurse were present at 
each procedure. Patients were then divided into two groups based on their diagnosis on the 
first visit to determine the effectiveness of the video colposcopy intervention in patients with 
two different diagnostic conditions. One group included participants who had cervical 
intraepithelial neoplasia (CIN) I,  CIN II, or CIN III and needed laser treatment. The other 




laser group) required two more visits- one for the laser treatment and another four months 
after receiving the laser treatment. Those who had no abnormalities detected on the first visit 
followed up in one year. The primary outcome was reduction in anxiety as measured by the 
difference in first and final STAI. In the laser group, STAI was found to be significantly 
reduced from the first to the final visit compared to those in the control group. Those in the 
laser video colposcopy group had an initial STAI of 51.82 (SD 14.22) and a final STAI of 
31.86 (SD 5.56), compared to those in the laser control group who had an initial STAI of 
51.62 (SD 12.56) and a final STAI of 40.29 (SD 7.06). The results of those who had no 
abnormalities detected on the first visit also reflect this result with those in the video 
colposcopy group having a first visit STAI of 49.05 (SD 11.03) and a final STAI of 34.70 
(SD 6.23) compared to those in the control group who had an initial STAI of 52.33 (SD 
13.46) and a final STAI of 44.78 (SD 9.89). While this study shows potential for the efficacy 
of video colposcopy to reduce anxiety, the study fails to provide certain details about the 
patients’ demographic information like race/ethnicity, socioeconomic status, or pre-existing 
comorbidities or mental health issues. These missing patient characteristics limit the 
interpretation of the results as it is unsure whether any of these patient characteristics may 
operate as confounders. The poor method of randomization and concealment also increases 
the risk of selection bias as their randomization technique is not truly random and it is based 
on an order that can be predicted. Nevertheless, despite these methodological weaknesses this 
early study demonstrated that video colposcopy may be a useful tool in decreasing anxiety in 
patients presenting for colposcopy. 
Another study by Kola et al. conducted in 2012 provides support for these results in a 




to have more information in stressful situations.31 In this study, the investigators assessed 
whether tailoring information to an individual’s coping style would decrease distress in 
patients presenting for first time colposcopy. 117 patients were recruited for the study and 
divided into low or high monitors. This classification was based on their scores from the 
Miller Behavioral Style scale which asks patients what they would do in hypothetical 
threatening situations. They were then randomized to three different groups: high 
information, low information, and control. Those randomized to the high information group 
watched their examination on a monitor with a video colposcope. Those randomized to the 
low information group watched and listened to a DVD with nature scenes and soothing 
instrumental music using a head-mounted display with headphones. Those in the control 
group had usual care. Both physiological measures (systolic blood pressure, diastolic blood 
pressure, and heart rate) and self-reported measures of anxiety using the STAI were recorded 
before and after the colposcopic procedure. Observational measures of distress including 
moaning and groaning were also recorded approximately five minutes after the exam had 
begun. All colposcopies were done by one nurse colposcopist. They found that those patients 
who were high monitors experienced a reduction in systolic blood pressure from pre-
colposcopy levels in both the high and low information groups. Low monitors showed an 
increase in systolic blood pressure during the exam compared to pre-colposcopy levels when 
in the high information group and a decrease in systolic blood pressure in the low 
information and control groups. Self-reported measures of anxiety failed to show any group 
differences while both high and low monitors exhibited fewer overt signs of distress in the 
low-information group. One strength of this study compared to the others is the use of 




medications that affect blood pressure and heart rate. Thus, the interpretations of the results 
may be biased. Future studies will need to incorporate this exclusion criteria to provide more 
compelling data. 
Recently, a larger prospective randomized multicenter controlled trial (n=225) 
conducted by Hilal et al. in Germany, demonstrated no significant reduction of anxiety with 
the use of video colposcopy.32 Their primary outcome was the mean reduction in anxiety 
scores and was not found to be significantly different between those who had a video 
colposcopy and those who had a traditional non-video colposcopy (-10.3 11.3 SD in 111 
women in the video colposcopy group and -10.3  11.0 SD in 105 women in the traditional 
colposcopy). This study demonstrated many aspects of a well-designed RCT. The study was 
a multicenter study conducted in both a doctor’s office setting and hospital setting expanding 
the generalizability of the study. Participants were given an informational leaflet to 
standardize medical knowledge about cervical cancer, HPV, and colposcopy; and the 
colposcopic exam was standardized decreasing possible sources of confounding. The method 
of concealment of allocation was also appropriate as they used a staff member not involved 
in the study to place the allocation slips into consecutively numbered opaque envelopes. 
They also calculated their sample size appropriately based on data from the study conducted 
by Chan et al. and recruited enough patients to achieve this calculated sample size.24 
 However, there are certain elements of their protocol that may help explain the 
negative result of their study. First, while they did use a computerized randomization tool to 
randomize patients, they utilized block randomization with block size four making it possible 
for the staff member who performed this random allocation to predict the allocation of some 




participants also showed some differences that may explain why video colposcopy did not 
reduce anxiety in these patients. In the video colposcopy group, there were more women who 
had concomitant disease (48 (43.2%) vs 38 (36.5%)) and more colposcopic findings 
suspicious for invasion (5 (4.5%) vs 0). Women who have concomitant diseases may already 
have a high burden of anxiety from preoccupation with their other disease making video 
colposcopy less effective. Similarly, women who are told that their colposcopy found lesions 
suspicious for invasion may not find video colposcopy helpful in reducing anxiety due to the 
heightened concern for cancer. Moreover, the majority of women in the study had major 
changes on colposcopic exam (48.6% in the video colposcopy group and 53.8% of the 
control group). This may explain why video colposcopy did not decrease anxiety as the 
graphic nature of some of these lesions may have served to increase anxiety. Thus, this study 
may have benefited from a multiple linear regression analysis with concomitant disease and 
colposcopic findings as independent variables. 
 In terms of analysis, the study reports that analysis was by intention to treat but nine 
protocol violations occurred and these patients were not included in the final analysis; three 
were from the video colposcopy group and six were from the control group.  Since not all 
randomized patients were analyzed, the data was not actually analyzed by the intention to 
treat principle. As this exclusion compromises the original randomization, this may be a 
source of bias as it may have created important prognostic differences between the groups. 
For example, if the six patients from the control group who were not included in the final 
analysis had more anxiety regarding colposcopy, this exclusion would skew the results so 
that the effect of video colposcopy to reduce anxiety was underestimated. The study also 




found that video colposcopy also did not reduce anxiety in either of these groups. However, 
this may be misleading as these subgroups were both small (n=55 for the most anxious 
patients vs n= 56 for the least anxious patients). Therefore, there may not have been enough 
people in each group to detect an effect size if there was one. Lastly, the generalizability of 
this study is limited as this study was conducted in Germany and important patient 
characteristics like race, ethnicity, and SES were not reported. It is therefore unclear whether 
these same effects would be seen in other patient populations.  
Thus, so far, the existing data remains both limited and mixed on the utility of video 
colposcopy in reducing anxiety in patients who present for first time colposcopy. 
Additional Demonstrated Benefits of Video Colposcopy 
While research in evaluating the efficacy of video colposcopy in decreasing patient 
anxiety levels undergoing colposcopy has not produced a definitive consensus, there have 
been many other demonstrated benefits of video colposcopy. One significant outcome is 
improved adherence to follow-up care. A review of literature by Eggleston et al. identified 
that some of the risk factors for decreased adherence to follow-up care include race and 
decreased knowledge of the cervical cancer screening process.7,33 A study looking at video 
colposcopy for improving adherence found significantly increased adherence rates from 50% 
in patients who underwent a traditional colposcopy to 80% in patients who had a video 
colposcopy.34 This is a significant finding as close surveillance and follow-up after a single 
colposcopy is indicated even in patients in whom no or low risk abnormalities are identified. 
Among women with high grade cervical abnormalities found at time of colposcopy, more 
immediate interventions are often indicated but subsequent short interval surveillance follow 




cervical cancer. Other demonstrated benefits of video colposcopy include improved patient 
knowledge as well as improved patient satisfaction although data has been variable with the 
latter.22,32,35,36  
Side Effects 
 The same side effects or complications from traditional colposcopy can also result 
from video colposcopy. These side effects or complications include: bleeding, cramping or 
pain, vaginal discharge, and in rare cases infection. Results from the study conducted by 
Hilal et al. indicate that patients experience a negligible level of discomfort and anxiety from 
watching the live video during video colposcopy. 32 
2.5 REVIEW OF RELEVANT METHODOLOGY 
Study Design and Blinding 
 Currently in the literature, most of the studies assessing video colposcopy have used 
an unblinded randomized controlled trial design.10,23,31,32 All of these studies assessing video 
colposcopy were unblinded due to the nature of the intervention. One study conducted on the 
efficacy of music to decrease pain during gynecological procedures used a single blind 
design where the participants were informed that they would be taking part in a study about 
pain relief but were not informed about the role of music until afterwards.27 As our 
intervention is similar, a single blind study design is justified and will decrease response bias. 
Previous studies lack any details about the blinding of outcome assessors and data analysts, 
but in order to decrease any potential sources of bias, this protocol is justified and will 
provide the most robust evidence to assess the utility of video colposcopy in decreasing 





Prior studies have used various methods to randomize their patients. One study 
randomized every second patient to the treatment group while another study had their 
patients select a random assignment slip.10,26 An additional study randomized patients by 
using week of scheduled appointment.15 These methods are not truly random as in the first 2 
cases, randomization depends on an order and in the third case, is subject to seasonal or 
temporal variation. Consequently, these techniques may not represent the best methods to 
randomize patients. Another study utilized block randomization (block size 4) with a 1:1 
allocation ratio. 32 While this method is more truly random, the staff member who performed 
the random allocation may be able to predict the allocation for later patients in the block, 
introducing a source of bias. Most other studies utilized a computer-generated random 
number series to allocate their patients to treatment or control.16,18,19,21,24,28 As this represents 
a truly random method to allocation patients, this randomization technique is the most 
appropriate for the proposed study to reduce selection bias. 
Primary Outcomes 
Most studies conducted on interventions to reduce anxiety in first time colposcopy 
patients have utilized the Spielberger State and Trait Anxiety Inventory (STAI) to measure 
anxiety.4,13,15,16,18-21,23,24,27,29,31,32 This inventory was originally developed by Spielberger et al. 
and is a self-reported measure of anxiety composed of 40 items- 20 items for the assessment 
of trait anxiety and 20 items for state anxiety.14 Trait anxiety refers to a more constant state 
of anxiety that an individual exhibits whereas state anxiety refers to anxiety that is more 
transient and experienced in a specific time and situation. Examples of statements assessing 
trait anxiety include: “I am a steady person” and “I worry too much over things that don’t 




calm.” These 20 items on both the state and trait versions of the STAI are rated on a 4-point 
Likert scale. Scores range from 20 to 80 with higher scores correlating with increasing 
anxiety. It has been suggested that 40 be the cutoff point to detect clinically significant 
anxiety.14,37 Cronbach’s alpha scores have been reported to be between 0.86-0.95 for working 
adults, college students, high school students, and military recruits.14 The test-retest 
reliability for the STAI in high school students and college students was found to be .68-.86 
for trait anxiety and.16-.62 for state anxiety.14 The low stability values for state anxiety are 
reasonable as it reflects a measure of anxiety in a specific time and situation. One 
disadvantage of this inventory is that it is a self-reported measure of anxiety. However, as 
various disciplines have utilized this inventory and found it to be a reliable and validated 
measure to detect anxiety, this inventory remains one of the gold standards to measure 
anxiety.14  
Some other studies have also utilized physiological measures as a proxy to measure 
anxiety like heart rate, systolic blood pressure, and diastolic measure in order to supplement 
self-reported measures of anxiety to obtain more objective data. 23,31 However, while these 
measures may be more objective, heart rate and blood pressure can be affected by various 
factors including but not limited to medication use, disease processes, or substance use.38 
Moreover, these physiological measures are proxies of anxiety and while they show promise, 
they have not been well-validated to measure anxiety. Therefore, as STAI has been more 
widely validated as a scale to measure anxiety, we will utilize the difference in pre-






The secondary outcomes we will measure include adherence to follow-up, patient 
satisfaction, patient knowledge of colposcopy and cervical dysplasia, and pain during the 
colposcopic procedure.  
Prior studies have measured patient adherence to follow-up in various ways. One 
study measured patient adherence rates and this was calculated by dividing the total follow-
up visits attended by the total number of appointments made.18 Another study measured 
adherence by whether or not the patient came to her follow-up or rescheduled. 34 As we are 
more interested into whether the patient comes to the next follow-up visit and not the overall 
adherence rate to follow-up appointments, we will use the latter method. 
Prior studies assessing patient satisfaction using video colposcopy have used highly 
variable methods ranging from using ratings of satisfaction using 3-5 point scales10,26,27 to 
utilizing a visual analog scale (VAS).28,29,32 Most of these scales are not well-validated nor 
are they specific to colposcopy. The PEACE-q was developed by Pop et al. and is the first 
questionnaire developed to assess satisfaction specifically in colposcopy patients. While it 
has only been used in one published article and it has not been widely validated yet, it has 
been demonstrated to have good psychometric properties with a Cronbach’s alpha of 
0.76.22,39 The questionnaire has 8 items which are rated on a 4-point Likert scale. Higher 
scores correspond with higher satisfaction with the colposcopy procedure. As this 
questionnaire demonstrates an acceptable internal consistency and is more specific to 
colposcopy practice, using this questionnaire is justified to assess for patient satisfaction.  
In prior studies, various questionnaires and interviews were developed to assess 
patient knowledge of colposcopy and cervical dysplasia. One study asked “What is your 




participants open-ended questions like “Do you know why you are scheduled for this 
appointment?” or “What is a colposcopy?”15 Other studies have used questionnaire formats 
that have ranged from true/false31 to multiple choice.13,18 As virtually none of these measures 
have been tested for their internal consistency or validity, these methods to measure patient 
knowledge provide insufficient evidence to determine whether they actually measure patient 
knowledge. One study conducted by Kola et al. utilized a 7-item questionnaire asking 
participants about their knowledge of smear tests, symptoms of cervical dysplasia, the 
meaning of smear tests, and what a colposcopy is.31 They found that their questionnaire 
Cronbach’s alpha was .86. This suggests that this questionnaire may be more reliable. While 
the specific details of the questionnaire are unclear, we will design our own true/false 
questionnaire based off of the mentioned topics covered in this study. An example of this 
knowledge questionnaire can be seen in Appendix E. 
To measure pain, prior studies have utilized the visual analog scale (VAS).24,26-29,32 
This scale is a self-reported tool that has been used extensively to study pain in various 
disciplines and has been well-validated.40 Usually, it is a 10 cm line labeled with “no pain” 
on one end and “the worst pain I have ever felt” on the other end. Participants will then mark 
on the line the corresponding intensity of pain they felt. Reliability of the VAS for acute pain 
has also been found to be high with an intra-class correlation coefficient ranging from .97- 
.99 in patients with acute pain in the Emergency Department.41,42 Moreover, it is applicable 
across a wide variety of populations and easy to administer. However, the VAS does have its 
limitations which include a ceiling effect and the inability to describe the quality of pain. In 






 Previous studies indicate potential confounders consist of the following: age, smoking 
behavior, history of anxiety or depression, prior colposcopy, having multiple providers 
perform the colposcopy due to differences in patient interaction style, referring cytology 
severity, prior medical knowledge, parity, marital status, age, body mass index (BMI), 
educational level, waiting time, and procedure time. 3,25,29,30,32 Some of these confounders 
were selected based on the hypothesis that they (age, parity, and educational level) may be 
inversely related with anxiety as these patients may have more experience with medical 
exams and will therefore be more relaxed.32 For BMI, it is hypothesized that those with a 
higher BMI may feel more ashamed during medical exams, thus influencing their anxiety 
levels during colposcopy.32 Higher BMI may also make the exam more difficult, increasing 
the procedure time and in effect increasing anxiety levels. Other variables have been 
demonstrated to have an independent effect on anxiety. In the study conducted by Hilal et al., 
on multiple linear regression analysis, they found that study center (P=.028), smoking 
behavior (P=.025) and BMI (P= .033) had a significant effect on mean reduction of anxiety 
scores. 32 Another study examining predictors of pre-procedural anxiety found women who 
were single and women who had children independently predicted higher pre-colposcopy 
state anxiety (p<0.05).3 The authors hypothesize that this may be due to a potential protective 
effect from having a partner in the case of being married and from fertility or family related 
concerns in the case of having children.3 Finally, longer waiting times and longer procedures 
have been suggested in the literature as possible confounders as they may negatively 
influence anxiety although to date, no empirical studies have yet demonstrated this with data. 




Some studies also chose to record whether a biopsy or endocervical curettage (ECC) 
was performed during the exam as well as the mean number of biopsies taken.24,26,29 In all 
three of the studies that recorded this data, none of these procedures were planned 
beforehand and patients were alerted to whether any of these procedures would be performed 
right before they were done. Chan et al. did not find that the performance of a biopsy during 
the procedure independently affected the anxiety levels of the participants while the other 
studies did not adjust for this variable in their data analysis. While the data so far has not 
demonstrated that the performance of a biopsy or ECC affects anxiety levels, it can be 
reasonably hypothesized that having these procedures performed during the colposcopic 
exam may influence anxiety levels as they may increase participants’ worries about cancer. 
Consequently, it is reasonable to suggest that the performance of a biopsy or ECC during the 
exam may act as a potential confounder.  
These potential confounders can ultimately be limited through appropriate exclusion 
criteria; the use of one clinician performing the colposcopic exam; recording baseline patient 
characteristics, waiting time and procedure time, and whether a biopsy or ECC was 
performed and how many; providing patients with an informational pamphlet concerning 
colposcopy and how to prepare for it; and through multivariate data analysis. 
Selection Criteria 
 Most studies reviewed have included patients who were age >18, had the ability to 
read, write, or communicate in the native language of the country, and who had been referred 
for first time colposcopy.10,26,29,31,32 The age criterion is based on data from previous studies 
that have found that cervical dysplasia is rarely found in women under the age of 20 and the 




participants to those >21 as this criterion will capture the target population, exclude 
adolescents who are not recommended to receive the Pap test, and simplify the protocol. The 
second criterion is another reasonable inclusion criterion as the intervention and the measures 
of anxiety all require the ability to communicate. In our proposed study, it will be reasonable 
to include English-speaking and Spanish-speaking patients to more fully capture our target 
population. Finally, the third criterion is justified as it has been hypothesized that previous 
experience with colposcopy may influence the anxiety levels of subsequent colposcopies. 
Patients excluded in most of the reviewed studies included those who were blind, had 
a prior colposcopy, had mental impairments, or were currently pregnant. These exclusion 
criteria were chosen in consideration of practicalities of the intervention and to eliminate 
potential confounders.15,18,24,27,32 Some prior studies have also chosen to exclude patients who 
have had a history of anxiety or depression but we will include these patients in our proposed 
study as we anticipate many of the people from our target population will have these 
disorders.29,32 Moreover, we believe that including this patient population may help to guide 
care in decreasing anxiety in patients who need it the most. 
Sampling Techniques 
Virtually all reviewed studies have utilized consecutive sampling to achieve their 
sample size.10,13,15,16,18-21,23,24,26-29,31,32 Consecutive sampling is a kind of nonprobability 
sampling technique, meaning that not every individual in the population has an equal 
likelihood of being selected for the study. However, due to the practical restraints of 
recruiting enough eligible patients, this will be an acceptable technique to recruit patients in 





 Previous studies have utilized some model of video colposcope to allow the patients 
to view their own colposcopy exam as an intervention. One study reported that viewing the 
monitor was encouraged but the participants were not forced to do so.23 Another study asked 
their participants to focused on the sensations they were feeling during the video 
colposcopy.31 Most studies had more than one clinician performing the colposcopies with the 
exception of one study. Increased efficiency in the clinic is one advantage of having several 
clinicians perform colposcopies. However, having more than one clinician perform the 
colposcopy introduces the possible confounder of clinician style of interaction with patients. 
To limit confounders, it is justified in our study to limit all colposcopies to one clinician. 
2.6 CONCLUSION 
 The existing literature on the efficacy of video colposcopy to decrease anxiety in first 
time colposcopy patients remains both scarce and inconclusive.  Half of the randomized 
controlled trials suggest a potential benefit while the other half do not support this 
conclusion. Study design problems limit the interpretation of these results and provide 
insufficient evidence to either support or refute their conclusions. Moreover, limited 
generalizability due to the inadequate reporting of certain patient demographics of these 
studies leaves a gap in the literature about the effect of video colposcopy in low income 
patients who are disproportionately affected by this problem. As a simple interactive and 
educational tool that does not incur any known additional risks with colposcopy, video 
colposcopy represents a promising tool for further evaluation in patients presenting for first 
time colposcopy. A well designed prospective single blind randomized controlled trial will 
provide more robust data and help to bridge this gap as it will be the first study that will 




patient population. Mean reduction of anxiety measured through the difference of pre-
colposcopy STAI scores from post-colposcopy STAI scores will provide meaningful results 
on the effect of video colposcopy on anxiety while patient adherence to follow-up, patient 
knowledge of colposcopy and cervical dysplasia, patient satisfaction, and patient pain during 
the procedure as secondary outcomes will provide meaningful data on other potential benefits 
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Chapter 3: Study Methods 
3.1- STUDY DESIGN 
We will conduct a prospective single blind randomized controlled trial in low-income 
women referred to the Yale New Haven Hospital Women’s Center for first time colposcopy. 
Patients will be randomized to the intervention group or the control group using a computerized 
randomization tool. To implement a single blind design, we will inform patients that we are 
conducting a study on anxiety but will not inform them about the role of video colposcopy until 
the colposcopic exam is over. This will decrease performance bias. Due to the nature of the 
intervention, the clinician performing the colposcopy will not be blinded. Data analysts will be 
blinded to further decrease bias. 
3.2-STUDY POPULATION AND SAMPLING 
 Our study population will include women presenting to Yale New Haven Hospital’s 
Women’s Center (a U.S. safety net clinic serving a racially and ethnically diverse population of 
low-income women) for first cervical colposcopy. All patients who satisfy the inclusion and 
exclusion criteria will be eligible for the study and will be approached to participate in the study. 
We will use consecutive sampling to recruit patients until we have satisfied our calculated 
sample size of 286 patients total with 143 patients in each arm.  
Inclusion Criteria 
 Our inclusion criteria will include the following: ability to read, write or communicate in 
English or Spanish, age >21, Medicaid or uninsured insurance status, and referral for first time 
colposcopy. English and Spanish speakers will be included in this study as these are the most 
predominantly spoken languages in New Haven, CT. Those falling outside of these languages 




Women’s Center are able to participate in the study. Women over the age of 21 will be included 
to further simplify the protocol and exclude adolescents. Medicaid or uninsured insurance status 
will serve as a proxy for low-income individuals. 
Exclusion Criteria 
 Our exclusion criteria will include the following: presence of a language barrier, mental 
impairment, inability to provide informed consent, blindness, prior colposcopy, or current 
pregnancy. These exclusion criteria will be used due to the practical limitations of the 
intervention and to decrease the number of potential confounders.  
3.3-SUBJECT PROTECTION AND CONFIDENTIALITY 
 We will obtain Institutional Review Board (IRB) approval as dictated by the Yale IRB 
Policy 100 PR.1 Review by a Convened Institutional Review Board. For every eligible 
participant, we will require written, informed consent. As outlined in the Yale IRB policy 200 
Informed Consent for Human Research form, informed consent will be conducted in a clear and 
understandable manner to the participant. The consent form will outline the purpose of the study, 
the duration of participation, description of the procedures, and possible risks or discomforts. 
Possible benefits that can be reasonably expected as a result from the research will be relayed to 
the patient as well as any disclosures of any appropriate alternative procedures, if any, that may 
be beneficial to the participants. The consent form will further include confidentiality practices, 
investigator contact information should any questions or concerns arise, and a statement that 
research participation is completely voluntary and that the participant may discontinue 
participation at any time with no penalty. A signed copy will be given to the participant for 




 All staff members involved in the study will be required to successfully complete Health 
Insurance Portability and Accountability Act (HIPAA) training prior to the start of the study and 
carry out study protocols in accordance with HIPAA regulations. The research assistant will 
explain to participants their HIPAA rights and participants will also receive a brochure 
containing detailed information about HIPAA prior to signing the informed consent form. 
 The medical information collected throughout the duration of the study will be stored on 
a secure server with data encryption software. Access to this information will be restricted to the 
research team members directly involved in the study and will be password protected. Participant 
identifiers like name, date of birth, and medical record number will be replaced as soon as 
possible by a random computer-generated identification number to maintain participant privacy. 
3.4-RECRUITMENT 
 Patients referred to the Yale New Haven Hospital’s Women’s Center will be screened to 
participate in the study. Those who fulfill the inclusion and exclusion criteria will be eligible for 
the study. The research assistant will approach study participants during the initial consultation 
and inform them of the medical implications of the study. They will be informed that 
participating in the study is completely voluntary and that if they do decide to participate, 
informed consent will need to be obtained. Participants will not be compensated for participation 
in this study.  
3.5-STUDY VARIABLES AND MEASURES 
 We will utilize video colposcopy as the intervention and the model of video colposcope 
we will use will be the Cooper Surgical Leisegang Optik Model 2 video colposcope. This model 
is a photo swing colposcope with a Canon EOS Rebel Camera that has high quality German 




real time feed of the exam and participants will be encouraged to participate in their own care. 
Colposcopic findings will be discussed with the participant during the exam. The control will be 
a traditional non-video colposcopy. The patient will be unable to view her colposcopy if assigned 
the control group and colposcopy findings will be discussed with the participant after the exam 
has concluded. The primary outcome variable will be the reduction of anxiety as measured by the 
difference of pre-colposcopy and post-colposcopy STAI. An example of the STAI questionnaire 
we will use is shown in Appendix C. Secondary outcome variables will include patient 
adherence to follow-up, patient satisfaction, patient knowledge of colposcopy and cervical 
dysplasia, and patient pain during the procedure. Adherence to follow-up will be measured by 
whether or not the patient returns for the follow-up appointment or reschedules the original 
appointment. Patient satisfaction will be measured by the Patient’s Experience and Attitude 
Colposcopy Eindhoven Questionnaire (PEACE-q). An example of this questionnaire can be seen 
in Appendix D. Patient knowledge of colposcopy and cervical dysplasia will be measured by a 
post-colposcopy true/false questionnaire. A correct answer will equal 1 point while an incorrect 
answer will equal 0 points. A higher total score will correspond with better knowledge about 
cervical dysplasia and colposcopy. An example of this questionnaire can be seen in Appendix E. 
Patient pain during the procedure will be measure with the VAS. An example of the VAS we 
will use is shown in Appendix F. 
3.6-METHODOLOGY CONSIDERATIONS 
Blinding 
 The participants will be blinded to the intervention. We will ask eligible patients to 
participate in a study about reducing anxiety but we will not inform the patients about the role of 




blinded. Outcome assessors and data analysts will be blinded to which group participants were 
randomized, in order to decrease information bias. 
Assignment of Intervention 
 Patients will be assigned to treatment or control groups through a computerized 
randomization tool by a nurse not directly involved with the study. These allocation lists will 
then be placed into opaque envelopes to be opened right before the colposcopy. Participants will 
be allocated in a 1:1 ratio.  
Monitoring of Adverse Events 
 At follow-up, study participants will be asked if they had experienced any complications 
as a result of the colposcopy including: bleeding, abdominal or pelvic pain, vaginal discharge, or 
signs of infection like fever. Should any of these patients experience any concerning symptoms 
in the days following colposcopy, they will be informed to call the clinic and be evaluated. If a 
patient fails to show up for their follow-up appointment, patients will be called over the phone to 
reschedule their original appointment and asked about any of these complications. 
Data Collection 
 The women who agree to participate in the study and give informed consent will fill out 
either the English or the Spanish version of the STAI questionnaire as well as baseline patient 
demographics prior to the colposcopic exam. Immediately after the colposcopy, patients will fill 
out another questionnaire containing only the state version of the STAI, the true/false patient 
questionnaire, PEACE-q questionnaire, and the VAS. Data on participant adherence to follow-up 
will be collected as follows: those who attend their follow-up appointment or reschedule will be 
recorded as adherent while whose fail to do either of those will be considered non-adherent.  




 Our sample size calculation is based on data from Danhauer et al. who has a similar 
patient population to our target population and Chan et al. who found music to decrease anxiety 
in first time colposcopy patients.1,2  In the study by Danhauer et al., the mean change in STAI 
with traditional colposcopy was 2.6. In the study conducted in 2003 by Chan et al. a mean 
change in STAI of 7.11(SD of 12.84) was found in the music group. Assuming that this 
intervention will have a similar or non-inferior effect, 7.11-2.6=4.5 which will be the estimated 
effect size. Thus, a sample size of 256 will be required to detect an effect size of 4.5 with an  of 
5% and a power of 80%. Assuming a 10% drop out rate and to ensure an even number of 
participants in each arm,  a conservative sample size of 286 will be required with 143 in each 
arm. The sample size calculation is included in Appendix B. 
Data Analysis 
 Descriptive statistics will include age, BMI, smoking behavior, race/ethnicity, SES 
bracket, educational level, parity, marital status, referring cytology, and current concomitant 
disease. They will be reported as means and standard deviation for parametric data or as medians 
and interquartile range for non-parametric data. Categorical data will be reported as relative 
frequencies. The primary outcome will be mean reduction in STAI and will be reported as means 
and standard deviation. Correspondingly, we will use a t test for the statistical analysis. The 
secondary outcomes will be adherence to follow-up, patient satisfaction, patient knowledge, and 
pain during the procedure. Patient adherence to follow-up will be reported as proportions. We 
will use the Chi Square test for statistical analysis. Patient satisfaction will be measured with the 
PEACE-q and will be reported as means and standard deviation. Accordingly, we will use the t 
test for statistical analysis. Patient knowledge will be assessed using a true/false questionnaire. A 




reported as means and standard deviation. Correspondingly, we will utilize a t test for statistical 
analysis. Finally, we will measure pain during the procedure using VAS and it will be reported as 
means and standard deviation. For statistical analysis we will use the t test for statistical analysis. 
A significance of P < 0.05 will be considered achieving statistical significance and all statistical 
tests will be two-tailed. Analysis will be done under the intention to treat principle. To account 
for the effect of potential confounders, multiple linear regression will be performed with the 
reduction in STAI scores as the dependent variable and study group, age, BMI, smoking 
behavior, race, SES, marital status, waiting time, procedure time, performance of a biopsy or 
ECC, and level of education as independent variables. Baseline characteristics of all participants 
will be obtained at the initial consultation. An example of these characteristics can be seen below 
in Table 1. 
Table 1: Participant Baseline Characteristics 















































































































Body Mass Index (kg/m2) Median/ IQ range Median/ IQ 
range 
Whitney U 
Waiting time in waiting room 
(minutes) 
Mean SD Mean SD T-test 
Colposcopy procedure time 
(minutes) 
Mean SD Mean SD T-test 
Current smoker  (n)% (n)% Chi square 
History of anxiety or depression (n)%  (n)% Chi square 
Current use of any SSRIs or 
benzodiazepines 
(n)% (n)% Chi square 
Current concomitant disease 
(yes/no)* 

































Number of biopsies taken Mean SD Mean SD T-test 
*Current concomitant disease will be recorded via patient self-report and will constitute an answer of yes if patient 
is currently being evaluated or treated for any medical conditions 
 
3.6- TIMELINE AND RESOURCES 
 Our study will be performed over a two-year time period. This time frame includes 
recruitment, data collection, and statistical analysis. Currently, the Yale New Haven Hospital 




(LEEPs) every week. Based on this data and our consecutive sampling method, we will 
conservatively estimate that it will take approximately 6 months to recruit the necessary number 
of eligible patients accounting for both patients who choose not to participate in the study and a 
10% dropout rate. Data collection will occur simultaneously and follow-up will take up to a 
maximum of one year. We expect data analysis to take 1-3 months. 
Our study will require one principle investigator, one co-principle investigator, one 
gynecologist trained in colposcopy, one colposcopy clinic nurse, and one Spanish speaking 
research assistant. The research assistant will help with recruitment and serve as a resource for 
participants to ask any questions should they have any when approached for the study. The 
colposcopy nurse will help carry out the protocols and oversee patients while they are filling out 
their questionnaires. The gynecologist trained in colposcopy will perform all colposcopies 
regardless of which group participants were randomized, in order to limit the confounding effects 
of having multiple providers perform the colposcopic exam. The principle investigator and co-
principle investigator will oversee the study as a whole to ensure protocols are being carried out 
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Chapter 4: Conclusion 
4.1 -ADVANTAGES AND DISADVANTAGES 
 This proposed study serves to synthesize existing literature to provide more robust 
evidence on the efficacy of video colposcopy to reduce anxiety in a patient population that has 
yet to be studied. One key advantage of this study over previous studies is the utilization of 
design protocols intended to minimize bias. Previous studies on video colposcopy have been 
unblinded due to the nature of the intervention. 1-4 Our study has the advantage of a single blind 
design to decrease performance and ascertainment bias. Next, the use of a single provider to 
perform the colposcopy and adjusting for several important confounders in the data analysis 
increases the likelihood that we are assessing the true relationship between video colposcopy and 
anxiety. As a result, these design elements will produce more robust and accurate results. Our 
secondary outcome of patient adherence to follow-up may also provide more evidence in the 
existing literature about improving patient adherence with a larger sample size.5 Finally, a major 
advantage our study has compared to the existing literature is the new data that will be obtained 
regarding anxiety reduction with video colposcopy in low-income patients. Overall, the proposed 
study will provide more compelling evidence on the efficacy of video colposcopy to decrease 
anxiety, in a population previously unstudied. 
 Disadvantages of our study include not being able to blind the gynecologist performing 
the colposcopies, the limited external validity of the study, and the use of a self-reported measure 
of anxiety. While we will be blinding participants to the intervention, we will be unable to blind 
the gynecologist who will perform the colposcopies due to the nature of the intervention. This 
introduces a source of performance and ascertainment bias. Studying low-income patients also 




colposcopy’s effect on anxiety in this population and considering that they are the most 
negatively affected by cervical cancer, the results of this study will contribute important and 
meaningful data to the existing literature. Finally, as we have chosen to use STAI as our measure 
of anxiety and it is a self-reported index of anxiety, we will only have subjective data and no 
objective measure of anxiety. However, as STAI has been the gold standard to measure anxiety 
across various disciplines, we believe that this limitation is acceptable.  
4.2-CLINICAL AND/OR PUBLIC HEALTH SIGNIFICANCE 
 Routine cervical cancer screening is the pillar of prevention that has helped decrease the 
incidence and prevalence rate of cervical cancer in the U.S. since the 1950’s. However, recent 
data indicates that these trends are stagnating indicating the need for improvements in 
management and screening.6 Studies examining predictors of poor screening indicate that anxiety 
is a significant barrier.7,8 A wealth of studies examining interventions to decrease this barrier 
exist in the current literature but no single intervention has demonstrated consistent results. A 
few previous studies have explored the effect of using video colposcopy to reduce anxiety in first 
time colposcopy patients but these studies have design shortcomings and have produced mixed 
results. Furthermore, the results of current literature remain limited to certain populations. The 
lack of reporting of certain demographic data from previous studies leaves the effect of video 
colposcopy on anxiety in low income patients unknown and an area of significant interest. 
  Results from this study will provide novel and quality data on whether video colposcopy 
has any utility in decreasing anxiety in low-income patients. This may in turn establish video 
colposcopy as a simple and easily employed tool for colposcopy clinics to decrease anxiety to 




provide meaningful data to guide future directions in finding a useful intervention to decrease 
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Appendix A: Consent Forms 
 
CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT 
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN HOSPITAL 
WOMEN’S CENTER 
 
Study Title: VIDEO COLPOSCOPY FOR DECREASING ANXIETY IN A LOW-INCOME 
SETTING 
Principal Investigator: Sangini Sheth, MD, MPH 
Co-Principal Investigator: Jessica Zheng, PA-SII 
Funding Source: Yale University School of Medicine Physician Associate Program 
 
Invitation to Participate and Description of Project: 
 
 You are invited to participate in a research study about interventions to reduce anxiety in 
first time colposcopy patients. You have been asked to participate because you are over the age 
of 21 and have been referred for colposcopy for the first time following an abnormal Pap test 
result. Approximately 286 patients will participate in this study. 
In order to decide whether or not you wish to be a part of this research study you should 
know enough about its risks and benefits to make an informed decision. This consent form gives 
you detailed information about the research study, which a member of the research team will 
discuss with you. This discussion should go over all aspects of this research: its purpose, the 
procedures that will be performed, any risks of the procedures, possible benefits and possible 
alternative treatments. Once you understand the study, you will be asked if you wish to 
participate; if so, you will be asked to sign this form. You will receive a copy of this signed form 
for your records. 
Description of Procedures: 
 
➢ If you decide to participate in this study, you will be randomly assigned to one of two 
groups. The first group will undergo colposcopy with the intervention and the second 
group will undergo a traditional colposcopy. Randomization will be achieved with a 
random computer-generated sequence.  
➢ Prior to undergoing your colposcopy, you will be asked to fill out some demographic 
information as well as some questionnaires regarding your level of anxiety. We ask that 
you complete these questionnaires to the best of your ability. 
➢ Following your colposcopy, you will be asked to complete a couple of questionnaires 
about anxiety, pain, your knowledge of cervical cancer/colposcopy, and your overall 
colposcopy experience. 
➢ Depending on which group you have been randomized to, the provider performing the 
colposcopy will inform you of the findings during the exam or after. The same provider 
will perform all colposcopies in the study. 
➢ After the colposcopy, you will be asked to set up a follow-up appointment to monitor for 




end of your enrollment of this study. We anticipate the total enrollment time of this study 
to be a maximum length of 12 months but depending on your findings, the enrollment 
time may be shorter. 
➢ You will be alerted of any important or significant findings that are discovered during the 
course of your participation in this study that may affect your willingness to continue 
your participation. If we find that one method offers better outcomes than the other, we 
will conclude the study and offer the better method to all of our participants. 
➢ You may voluntarily withdraw from this study at any time. 
➢ A description of this clinical trial will be available on http://www.Clinicaltrials.gov as 
required by U.S. Law. This website will not include any information that will personally 
identify you. The purpose of this database is to allow everyone to see what research has 
been done and what research is currently being done. At most, the website will include 
summary of the results. You can search this website at any time. If research results are 
published, your personal information will not be given. 
 
Risks and/or Inconveniences: 
 
➢ Colposcopy can be an uncomfortable and anxiety provoking procedure for many patients. 
We will do our best to maintain an environment that is as comfortable as possible within 
our means. 
➢ The risks of colposcopy include some pain or discomfort during and after the procedure. 
A previous study found that around 14-18% of women experienced one of these symptoms 
after colposcopy. Extremely rare complications of colposcopy include severe abdominal 
or pelvic pain, heavy bleeding lasting longer than two weeks, purulent vaginal discharge, 
fever or chills, and infection. Should any of these symptoms arise following the procedure, 
you should contact the clinic to be evaluated and treated. Colposcopy will not make it more 
difficult to become pregnant. 
➢ Biopsies or endocervical curettage may need to be performed during the colposcopy 
depending on the colposcopy findings. Rare complications of these procedures include 
bleeding or infection of the site. Should there be any significant bleeding we will apply 
ferric subsulfate (Monsel’s solution) with a cotton swab to the area. Signs of infection may 
present as pelvic pain, purulent vaginal discharge, or abnormal bleeding or clotting. If any 
of these signs or symptoms are present after the procedure, you should contact the clinic to 
be evaluated and treated for possible infection. 
➢ The intervention being studied has reported no additional major risks or side effects 
compared to standard traditional colposcopy. 
Benefits 
➢ This research may provide more conclusive evidence on methods to decrease anxiety in 
low income patient populations presenting for first time colposcopy. 
➢ This study may improve current colposcopy practice and potentially increase cervical 
cancer screening rates. 
➢ We expect this study to directly benefit low income populations and indirectly benefit other 







There will be no compensation for participation in this study and no costs will be associated with 




If you choose not to participate in this study, you may proceed with a traditional colposcopy. Other 
strategies used to decrease anxiety in first time colposcopy patients include informational 
pamphlets, video information, counselling sessions, guided imagery, targeted information, and 
music. You will be given an informational pamphlet at the initial consultation but other strategies 
will not be used in this study. 
 
Confidentiality 
Any identifiable information that is obtained in connection with this study will remain 
confidential and will be disclosed only with your permission or as required by U.S. or State law. 
Examples of information that we are legally required to disclose include abuse of a child or 
elderly person, or certain reportable diseases. Information will be kept confidential by replacing 
personal identifiers with identification numbers on study forms, storing signed forms in locked 
cabinets, and storing collected data on a password protected, HIPAA compliant, encrypted 
server. When the results of the research are published or discussed in conferences, no 
information will be included that would reveal your identity unless your specific permission is 
obtained.  
We understand that information about your health is personal, and we are committed to 
protecting the privacy of that information. If you decide to be in this study, the researcher will 
collect information that identifies you personally. This may include your name and address, 
telephone number, and email address, or mobile phone number. This information will be de-
identified at the earliest reasonable time after we receive it, meaning we will replace your 
identifying information with a code that does not directly identify you. The data will be kept in 
this form until 2 weeks after acquisition of all study data, at which the personal information will 
be destroyed and the data will become anonymous. The data will remain in this anonymous form 
indefinitely.  
The information about your health that will be collected in this study includes:  
• Records about past medical history 
• Records about phone calls made as part of this research study 
• Records about your study visits  
Information about you and your health that might identify you may be used by or given to: 
• Representatives from Yale University, the Yale Human Research Protection Program and 
the Yale Human Investigation Committee (the committee that reviews, approves, and 
monitors research on human subjects), who are responsible for ensuring research 




• Those individuals at Yale who are responsible for the financial oversight of research 
including billings and payments  
• The Principal Investigator (Dr. Sangini Sheth)  
• Co-Investigators and other investigators  
• Study Coordinator and Members of the research team  
By signing this form, you authorize the use and/or disclosure of the information described above 
for this research study. The purpose for the uses and disclosures you are authorizing is to ensure 
that the information relating to this research is available to all parties who may need it for 
research purposes.  
All health care providers subject to HIPAA (Health Insurance Portability and Accountability 
Act) are required to protect the privacy of your information. The research staff at the Yale 
School of Medicine are required to comply with HIPAA and to ensure the confidentiality of your 
child’s information.  
If you choose to participate in this study, the investigators will check your electronic medical 
record at Yale (EPIC) to make sure you qualify. Any access to your electronic medical record 
will be done consistent with HIPAA regulations.  
Some of the individuals or agencies listed above may not be subject to HIPAA and therefore may 
not be required to provide the same type of confidentiality protection. They could use or disclose 
your information in ways not mentioned in this form. However, to better protect your health 
information, agreements are in place with these individuals and/or companies that require that 
they keep your information confidential.  
You have the right to review and copy your health information in your medical record in 
accordance with institutional medical records policies. This authorization to use and disclose 
your health information collected during your participation in this study will never expire.  
In Case of Injury 
 
If you are injured while participating in the study, seek treatment and contact the study doctor as 
soon as you are able. 
 
Yale School of Medicine and Yale-New Haven Hospital do not provide funds for the treatment of 
research-related injury. If you are injured as a result of your participation in this study, treatment 
will be provided. No additional financial compensation for injury or lost wages is available. You 
do no give up any of your legal rights by signing this form. 
 
Voluntary Participation and Withdrawal 
 
Subjects have the right to withdraw their data once it has been collected. However, this will only 
be possible before it has been deidentified. Once data has been collected and deidentified, subjects 





Refusing to participate will involve no penalty or loss of benefits to which you are otherwise 
entitled (such as your health care outside the study, the payment for your health care, and your 
health care benefits). However, you will not be able to enroll in this research study or receive study 
procedures as a study participant if you do now allow us to use your information as part of this 
study. You do not give up any of your legal rights by signing this form. 
 
Withdrawing from the Study 
 
If you do not become a subject, you are free to stop and withdraw from this study at any time 
during its course. To withdraw from the study, you can call a member of the research team at any 
time and tell them that you no longer want to take part. This will cancel any future appointments. 
 
Withdrawing from the study will involve no penalty or loss of benefits to which you are otherwise 
entitled. It will not harm your relationship with your own doctors or with Yale-New Haven 
Hospital or Yale University. 
 
When you withdraw from the study, no new health information identifying you will be collected 
after that date. Information that has already been gathered may still be used and given to others 





We have used some technical terms in this form. Please feel free to ask about anything you do not 
understand and to consider this research and the consent form carefully- as long as you feel 




I have read (or someone has read to me) this form and have decided to continue to participate in 
the project described above.  Its general purposes, the particulars of involvement and possible 
hazards and inconveniences have been explained to my satisfaction. My signature also indicates 
that I have received a copy of this consent form. 
 
 
Name of Subject:_____________________________ 












___________________________________________          _____________________   
Signature of Principal Investigator                                         Date 
                               
 or  
 
___________________________________________ ___________________ 
Signature of Person Obtaining Consent  Date 
 
 
If you have further questions about this project or if you have a research-related problem, you 
may contact the Principal Investigator Sangini Sheth MD,MPH at (***)***-**** or the Co-
Principal Investigator Jessica Zheng at (***)***-****. If you would like to talk with someone 
other than the researchers to discuss problems, concerns, and questions, offer input, discuss 
situations in the event that a member of the research team is not available, or if you have any 
questions concerning your rights as a research subject, you may contact the Human Investigation 




















SHORT FORM WRITTEN CONSENT 
FOR SUBJECTS WHO ARE UNABLE TO READ ENGLISH 
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN HOSPITAL 
WOMEN’S CENTER 
 
Study Title: VIDEO COLPOSCOPY FOR DECREASING ANXIETY IN A LOW-INCOME 
SETTING 
Principal Investigator: Sangini Sheth, MD, MPH 
Co-Principal Investigator: Jessica Zheng, PA-SII 
Funding Source: Yale University School of Medicine Physician Associate Program 
 
CONSENT TO PARTICIPATE IN RESEARCH 
You are being asked to participate in a research study. 
 
Before you agree, the investigator must tell you about the (i) purposes, procedures, and duration 
of the research; (ii) any procedures which are experimental; (iii) any reasonably foreseeable 
risks, discomforts, and benefits of the research; (iv) any potentially beneficial alternative 
procedures or treatments; and (v) how confidentiality will be maintained. 
 
Where applicable, the investigator must also tell you about (i) any available compensation or 
medical treatment if injury occurs; (ii) the possibility of unforeseeable risks; (iii) circumstances 
when the investigator may halt your participation; (iv) any added costs to you; (v) what happens 
if you decide to stop participating; (vi) when you will be told about new findings which may 
affect your willingness to participate; and (vii) how many people will be in the study. 
 
If you agree to participate, you must be given a signed copy of this document and a written 
summary of the research. 
 
You may contact either the Principal Investigator Dr. Sangini Sheth at (***)***-**** or the Co-
principal investigator Jessica Zheng at (***)***-**** any time you have any questions about the 
research or what to do if you are injured. You may contact the Yale Human Research Protection 
Program (HRPP) at (203)785-4688 if you have any questions about your rights as a research 
subject. 
 
Your participation in this research is voluntary and you will not be penalized or lose benefits if 
you refuse to participate or decide to stop. 
 
Signing this document means that the research study, including the above information, has been 
described to you orally, and that you voluntarily agree to participate. 
 
___________________________________________          _____________________   






Signature of Witness   Date 




By signing this form, you are indicating that: 
• The information in the summary document as well as any additional information 
conveyed by the research person obtaining consent was presented to the subject in a 
language preferred by and understandable to the subject 
• The subject’s questions were interpreted and the response of the person obtaining consent 
were presented in a language preferred by and understandable to the subject 
• At the conclusion of the consent conference the subject was asked in a language preferred 


































SPANISH SHORT FORM WRITTEN CONSENT 
FORMULARIO ABREVIADO DE CONSENTIMIENTO ESCRITO 
PARA INDIVIDOS QUE NO HABLAN NI LEEN EL INGLÉS  
ESCUELA DE MEDICINA DE LA UNIVERSIDAD DE YALE-HOSPITAL YALE-NEW 
HAVEN CENTRO DE MUJERES 
 
Nombre del estudio: VIDEO COLPOSCOPIA PARA DISMINUIR LA ANSIEDAD EN UNA 
CLÍNICA DE BAJOS INGRESOS 
Investigador principal: Sangini Sheth, MD, MPH 
Investigadora codirectora: Jessica Zheng, PA-SII 
Fuente de financiamiento: Escuela de medicina de la Universidad de Yale Programa de medico 
asociado 
 
CONSENTIMIENTO PARA PARTICIPAR EN LA INVESTIGACIÓN 
 
Se le está solicitando su participación en un estudio de investigación. 
 
Antes de aceptar, el investigador debe informarle sobre: (i) los propósitos, los procedimientos, y 
la duración del estudio; (ii) todo los procedimiento que seas experimentales; (iii) todos posibles 
riesgos, incomodidad o beneficio que se puede prever como resultado del estudio; (iv) cualquier 
procedimiento o tratamiento alternativo que tenga potencial de beneficiarle; y (v) cómo se 
mantendrá la confidencialidad. 
 
Cuando sea aplicable, el investigador también debe informarle sobre: (i) cualquier compensación 
o atención médica disponible en caso de lesion; (ii) la posibilidad de riesgos impredecibles; (iii) 
situaciones en las que el investigador pueda cesar su participación; (iv) cualquier costo adicional 
para usted; (v) lo que pasa si usted decide interrumpir su participación; (vi) cuándo se le 
informará sobre nuevos hallazgos que puedan afectar su deseo en participar; (vii) cuántas 
personas participarán en el estudio; y su derecho de revocar (anular) su autorización para el uso o 
la divulgación de sus datos de salud confidenciales por parte de los investigadores. 
 
Si usted acepta participar, debe recibir una copia firmada de este documento y un resumen del 
estudio por escrito. 
 
Puede comunicarse con La Doctora Sangini Seth al (***)***-**** o con Jessica Zheng al 
(***)***-**** a qualquier momento que tenga preguntas sobre el estudio o lo que debe hacer si 
se encuentra herido. Puede comunicarse con el Programa de Protección de Investigación 
Humana de Yale (HRPP) al (203)785-4688 si tiene preguntas sobre sus derechos como sujeto de 
una investigación. 
 
Su participación en esta investigación es voluntaria, y usted no será penalizado ni perderá 





Al firmar este documento, usted consenta que el estudio de investigación, incluyendo la 
información previa, le ha sido explicado oralmente, y que usted acepta participar 
voluntariamente. 
___________________________________________             _____________________          
Firma del participante/LAR        Fecha 
                                 
 
___________________________________________    ___________________ 
Firma del testigo       Fecha 





Al firmar este formulario, usted afirma que: 
• La información en el Documento Sumario (el formulario abreviado) y toda la 
información adicional comunicada por el investigador obteniendo el consentimiento del 
sujeto, se presentó al sujeto en su idioma preferido y de manera comprensible. 
• Las preguntas del sujeto fueron interpretadas y las respuestas de la persona obteniendo el 
consentimiento fueron transmitidas al sujeto en su idioma preferido y de la manera 
comprensible. 
• Al cierre de la conferencia de consentimiento, se le preguntó al sujeto en su idioma 





___________________________________________    ___________________ 










Appendix B: Sample Size Calculation 
The sample size calculation was based on a t-test calculator comparing two independent means 
assuming normal distribution with the following study parameters: 
 
• Alpha, the probability of a type-I error (finding a difference when a difference does 
not exist): 0.05  
• Beta, the probability of a type-II error (not detecting a difference when one actually 
exists: 0.2 
• Power: 0.8 
The following equation was used to calculate the sample size: 
 
Assuming a standard deviation of 12.84 units, the study would require a sample size of 128 for 
each group (total sample size of 256) to achieve a power of 80% and a level of significance of 
5% (two sided), for detecting a true difference in means between the test and the reference group 
of 4.5. 
Assuming a 10% drop out rate and to ensure an even number of participants in each arm, a final 
conservative sample size of 286 will be required with 143 in each arm. 
Reference: Dhand, N. K., & Khatkar, M. S. (2014). Statulator: An online statistical calculator. 
















Directions: A number of statements which people have used to describe themselves are given 
below. Read each statement and then circle the appropriate value to the right of the statement to 
indicate how you feel right now. There are no right or wrong answers. Do not spend too much 





Sometimes Often Almost 
Always 
1. I feel calm. 0 1 2 3 
2. I feel secure. 0 1 2 3 
3. I am tense. 0 1 2 3 
4. I feel strained. 0 1 2 3 
5. I feel at ease. 0 1 2 3 
6. I feel upset. 0 1 2 3 
7. I am presently worrying over possible 
misfortunes. 
0 1 2 3 
8. I feel satisfied. 0 1 2 3 
9. I feel frightened. 0 1 2 3 
10. I feel comfortable. 0 1 2 3 
11. I feel self-confident. 0 1 2 3 
12. I feel nervous. 0 1 2 3 
13. I am jittery. 0 1 2 3 
14. I feel indecisive. 0 1 2 3 
15. I am relaxed. 0 1 2 3 
16. I am content. 0 1 2 3 
17. I am worried. 0 1 2 3 
18. I feel confused. 0 1 2 3 
19. I feel steady. 0 1 2 3 






Directions: A number of statements which people have used to describe themselves are given 
below. Read each statement and then circle the appropriate value to the right of the statement to 
indicate how you generally feel. There are no right or wrong answers. Do not spend too much 




Sometimes Often Almost 
Always 
21. I feel pleasant. 0 1 2 3 
22. I feel nervous and restless. 0 1 2 3 
23. I feel satisfied with myself. 0 1 2 3 
24. I wish I could be as happy as others seem to 
be. 
0 1 2 3 
25. I feel like a failure. 0 1 2 3 
26. I feel rested 0 1 2 3 
27. I am “calm, cool, and collected” 0 1 2 3 
28. I feel that difficulties are piling up so that I 
cannot overcome them. 
0 1 2 3 
29. I worry too much over something that really 
does not matter. 
0 1 2 3 
30. I am happy. 0 1 2 3 
31. I have disturbing thoughts. 0 1 2 3 
32. I lack self-confidence. 0 1 2 3 
33. I feel secure. 0 1 2 3 
34. I make decision easily. 0 1 2 3 
35. I feel inadequate. 0 1 2 3 
36. I am content. 0 1 2 3 
37. Some unimportant thoughts run through my 
mind and bothers me. 
0 1 2 3 
38. I take disappointments so keenly that I can’t 
put them out of my mind. 
0 1 2 3 
39. I am a steady person. 0 1 2 3 
40. I get in a state of tension or turmoil as I think 
over my recent concerns and interests. 
0 1 2 3 
 
Reference: Spielberger CD, Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. Manual 






Appendix D: PEACE-q Questionnaire 
PATIENT’S EXPERIENCE AND ATTITUDE COLPOSCOPY EINDHOVEN 
QUESTIONNAIRE (PEACE-Q) 
 
Directions: A number of statements about your experience with colposcopy are given below. 
Read each statement and then circle the appropriate value to the right of the statement to indicate 
how strongly you agree or disagree with the statement. There are no right or wrong answers but 





Agree Disagree Strongly 
disagree 
1. I was well-informed about the colposcopy. 1 2 3 4 
2. I was preoccupied with the possible 
outcome of the colposcopy. 
1 2 3 4 
3. I feel stressed about the colposcopy. 1 2 3 4 
4. I was worried about the outcome of the 
colposcopy. 
1 2 3 4 
5. I was worried about the possible further 
treatment options. 
1 2 3 4 
6. The gynecologist put me at east. 1 2 3 4 
7. I am satisfied about the way I received the 
results. 
1 2 3 4 
8. I was well-informed about the next steps 
after the colposcopy. 
1 2 3 4 
 
 
Reference: Pop VJM, Wouters T, Bekkers RLM, Spek VRM, Piek JMJ. Development of the 
Patient’s Experience and Attitude Colposcopy Eindhoven Questionnaire (PEACE-q). BMC 














Appendix E: True/False Questionnaire 
Directions: Below is a true/false questionnaire about colposcopy and cervical dysplasia. Circle 
either True or False. Please answer to the best of your ability. 
 
1. True   /    False    An abnormal Pap test means that I definitely have cancer. 
2. True   /    False    If abnormal cells are found during my colposcopy, a biopsy will be done. 
3. True   /    False    Cervical dysplasia is another term for cancer. 
4. True   /    False    HPV infection is a risk factor for the development of cervical dysplasia. 
5. True   /    False    A Pap test is a test to detect pre-cancer and cancer. 
6. True   /    False    There are usually no symptoms when a person has cervical dysplasia. 
7. True   /    False    Colposcopy is a procedure used to examine my cervix after an abnormal         
Pap test result. 
Appendix F: Visual Analog Scale 
Directions: Please mark with a vertical line through the horizontal line below to indicate your 
response to the question. 
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